After Hours
It may be riskier to trade before market opening and after market closing than during regular market hours. Since issuers often announce critical financial information outside regular trading hours. Extended-hours trading may result in wider spreads for particular securities due to lower liquidity and higher volatility.
Stocks Info
Precision Biosciences Inc is listed on the NASDAQ in the Healthcare sector while operating in the Biotechnology industry. The current market capitalization of Precision Biosciences Inc is $47.70M. A total of 0.86 million shares were traded on the day, compared to an average of 478.35K shares.
In the most recent transaction, Buehler Kevin bought 4,523 shares of DTIL for 4.67 per share on Mar 26 ’25. After the transaction, the Director now owns 13,235 company shares. In a previous transaction on Mar 26 ’25, Brown Melinda bought 1,839 shares at 4.75 per share. DTIL shares that Director owns now total 9,057.
Among the insiders who bought shares, Germano Geno J acquired of 3,250 shares on Mar 25 ’25 at a per-share price of $5.30. This resulted in the Director holding 11,057 shares of DTIL after the transaction. In another insider transaction, Amoroso Michael sold 964 shares at $5.56 per share on Mar 24 ’25. Company shares held by the President and CEO now total 109,540.
Despite rarely being accurate, price targets can exert some form of influence at times, and are often regarded as valuable by markets. In terms of 52-week highs and lows, DTIL has a high of $14.66 and a low of $3.61.
As of this writing, DTIL has an earnings estimate of -$2.42 per share for the current quarter. EPS was calculated based on a consensus of 1 estimates, with a high estimate of -$2.42 per share and a lower estimate of -$2.42.
Balance Sheet Annually/Quarterly
As well as showing the assets and liabilities of the company, the balance sheet also shows the amount invested in equity by investors. Investors can analyze a company’s future prospects by calculating its financial ratios based on this information. DTIL’s latest balance sheet shows that the firm has $143.66M in Cash & Short Term Investments as of fiscal 2021. There were $9.11M in debt and $35.98M in liabilities at the time. Its Book Value Per Share was $6.87, while its Total Shareholder’s Equity was $91.17M.
Analysts Opinion
After-hours and pre-market trading may carry slightly higher risks than regular market hours. As issuers often announce important financial information outside regular trading hours, extended-hours trading may result in wider spreads for a particular security. That is because extended-hours trading may result in lower liquidity and higher volatility. Currently, 0 analysts are providing their opinions on the stock. On a scale of 1 to 5, with 1 being Sell and 5 being Buy, the average analyst rating for DTIL is Buy with a score of 5.00.
